Top 10 Alternatives to DrugDev Spark Recently Reviewed By G2 Community
AI can help you find the answers. G2 helps you trust them.
Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.
How it works
The Gold Standard for Chemical Drawing and Research publications
Epocrates specializes in creating point-of-care digital solutions designed to enhance the practice of medicine.
Data sharing and collaborative drug design across the entire discovery team in real time.
Pluto Bio is a cloud-based platform empowering life sciences organizations to visualize and analyze complex biological data sets easily, with no coding required. Upload raw data from a wide variety of experiment types (qPCR, ELISA, RNA-seq, metabolomics, proteomics, and more), generate interactive results pages, and share them easily and securely with collaborators.
Clinical Trial Outcomes Databases form a quantitative framework to leverage valuable external data, providing key development insights to maximize the probability of success for a new drug. Clinical Trial Outcomes Databases, accessed through our online interactive CODEx interface, provide comprehensive and up-to-date data on major therapeutic areas.
Deep knowledge on pharmaceutical drugs - patents, suppliers, generics, formulation, and more.
Simulations Plus is a modeling and simulation software for pharmaceutical research.
BioSymetrics' Augusta is a first of its kind software framework and coding language for Biomedical AI/Machine Learning applications that include drug discovery, precision medicine and value based care. Augusta contains over 300 code blocks and an iterative AI core to normalize any biomedical data type including chemistry(compounds), imagery (fMRI etc.) , genetics, EMR systems and more.
MicroTracker allows you to track your brands performance against key competitors on primary market indicators with the ability to capture mentions for brands in your products treatment category.
Drug development includes the critical work of verification, elucidation, optimisation, and monitoring needed to take only the most promising molecules "small or large" through from clinic to market.